Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Surface Oncology, Inc.    SURF

SURFACE ONCOLOGY, INC.

(SURF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

SURFACE ONCOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
08/11/2020 | 07:08am EDT

Item 2.02 Results of Operations and Financial Condition. On August 11, 2020, Surface Oncology, Inc. (the "Company") announced Financial Results and Corporate Highlights for the three and six months ended June 30, 2020. A copy of the press release is being furnished as Exhibit 99.1 to this Report on Form 8-K.

The information in this Report on Form 8-K and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.



Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.

Exhibit
Number                                                 Description

                         Press release issued by S    urface Oncology, In    c. o    n     August
99.1                   11, 2020




                                       1

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses


share with twitter share with LinkedIn share with facebook
All news about SURFACE ONCOLOGY, INC.
10/26SURFACE ONCOLOGY : to Report SRF388 Preclinical Data at the Upcoming Internation..
AQ
10/26Surface Oncology to Report SRF388 Preclinical Data at the Upcoming Internatio..
GL
10/26SURFACE ONCOLOGY, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
09/16SURFACE ONCOLOGY : to Participate in the Oppenheimer Fall Healthcare Life Scienc..
AQ
09/16Surface Oncology to Participate in the Oppenheimer Fall Healthcare Life Scien..
GL
09/11SURFACE ONCOLOGY : to Participate in the H.C. Wainwright Global Healthcare Confe..
AQ
09/11Surface Oncology to Participate in the H.C. Wainwright Global Healthcare Conf..
GL
09/09SURFACE ONCOLOGY : to Present at the Baird Global Healthcare Conference
AQ
09/09Surface Oncology to Present at the Baird Global Healthcare Conference
GL
08/11Surface Oncology Reports Financial Results and Corporate Highlights for Secon..
GL
More news